Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
BG60033B2 - Метод за получаване на 4-(5,6,7,8-тетрахидроимидазо /1,5-а)пиридин-5-ил)бензонитрил-хидрохлорид в кристална полухидратна форма - Google Patents
[go: Go Back, main page]

BG60033B2 - Метод за получаване на 4-(5,6,7,8-тетрахидроимидазо /1,5-а)пиридин-5-ил)бензонитрил-хидрохлорид в кристална полухидратна форма - Google Patents

Метод за получаване на 4-(5,6,7,8-тетрахидроимидазо /1,5-а)пиридин-5-ил)бензонитрил-хидрохлорид в кристална полухидратна форма

Info

Publication number
BG60033B2
BG60033B2 BG093623A BG9362391A BG60033B2 BG 60033 B2 BG60033 B2 BG 60033B2 BG 093623 A BG093623 A BG 093623A BG 9362391 A BG9362391 A BG 9362391A BG 60033 B2 BG60033 B2 BG 60033B2
Authority
BG
Bulgaria
Prior art keywords
hydrochloride
tetrahydroimidazo
benzonitrile
hemihydrate
water
Prior art date
Application number
BG093623A
Other languages
English (en)
Inventor
Jutta Ibrahim
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BG60033B2 publication Critical patent/BG60033B2/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Liquid Crystal Substances (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Pyridine Compounds (AREA)

Abstract

Новата кристална полухидратна форма се използва в медицината. Тя е с повишена стабилност и много добра устойчивост при съхранение. Има формула по метода 4-(5,6,7,8-тетрахидроимидазо[1,5-а]пиридин-5-ил)бензонитрил или негова сол, различна от хидрохлоридната, взаимодейства с хлороводород в присъствие на вода. В случай, че една от формите на хидрохлорида съдържа по-малко вода от полухидрата, тя се третира допълнително с вода. Когато хидрохлоридът съдържа повече вода от полухидрата, той се обезводнява до получаване на полухидрат с посочената по-горе формула. 1 претенция
BG093623A 1990-01-12 1991-01-14 Метод за получаване на 4-(5,6,7,8-тетрахидроимидазо /1,5-а)пиридин-5-ил)бензонитрил-хидрохлорид в кристална полухидратна форма BG60033B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH10090 1990-01-12

Publications (1)

Publication Number Publication Date
BG60033B2 true BG60033B2 (bg) 1993-07-15

Family

ID=4179261

Family Applications (2)

Application Number Title Priority Date Filing Date
BG093623A BG60033B2 (bg) 1990-01-12 1991-01-14 Метод за получаване на 4-(5,6,7,8-тетрахидроимидазо /1,5-а)пиридин-5-ил)бензонитрил-хидрохлорид в кристална полухидратна форма
BG096793A BG61489B2 (bg) 1990-01-12 1992-08-18 Хемихидрат на 4-(5,6,7,8-тетрахидроимидазо (1,5-а) пиридин-5-ил/-бензонитрил хидрохлорид

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG096793A BG61489B2 (bg) 1990-01-12 1992-08-18 Хемихидрат на 4-(5,6,7,8-тетрахидроимидазо (1,5-а) пиридин-5-ил/-бензонитрил хидрохлорид

Country Status (32)

Country Link
US (1) US5098911A (bg)
EP (1) EP0437415B1 (bg)
JP (1) JP2694186B2 (bg)
KR (1) KR100191360B1 (bg)
CN (1) CN1037966C (bg)
AT (1) ATE125809T1 (bg)
AU (1) AU638085B2 (bg)
BG (2) BG60033B2 (bg)
CA (1) CA2033937C (bg)
CZ (1) CZ279823B6 (bg)
DE (1) DE59106101D1 (bg)
DK (1) DK0437415T3 (bg)
DZ (1) DZ1482A1 (bg)
ES (1) ES2075399T3 (bg)
FI (1) FI94528C (bg)
GR (1) GR3017027T3 (bg)
HU (1) HU216192B (bg)
ID (1) ID964B (bg)
IE (1) IE67512B1 (bg)
IL (1) IL96879A (bg)
MA (1) MA22040A1 (bg)
MT (1) MTP1076B (bg)
NO (1) NO175747C (bg)
NZ (1) NZ236735A (bg)
PH (1) PH27601A (bg)
PL (3) PL166500B1 (bg)
PT (1) PT96447B (bg)
RO (1) RO107408B1 (bg)
RU (2) RU2021271C1 (bg)
SA (1) SA93140021B1 (bg)
TN (1) TNSN91001A1 (bg)
ZA (1) ZA91229B (bg)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW208013B (bg) * 1990-03-01 1993-06-21 Daiichi Co Ltd
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (bg) * 1990-09-18 1994-06-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
JP2914324B2 (ja) 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
AU2011296015B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
EP2804863B1 (en) 2012-01-17 2015-12-02 Novartis AG New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor
WO2018078049A1 (en) 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
KR102923585B1 (ko) 2016-10-27 2026-02-04 다미안 파르마 에이쥐 알도스테론 합성효소 저해제
AU2019262310B2 (en) 2018-05-03 2025-03-13 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
AU638085B2 (en) 1993-06-17
CA2033937C (en) 2001-03-13
HK1000663A1 (en) 1998-04-17
FI910126L (fi) 1991-07-13
SA93140021B1 (ar) 2006-07-11
CZ279823B6 (cs) 1995-07-12
PH27601A (en) 1993-08-31
RU2088584C1 (ru) 1997-08-27
NO175747C (no) 1994-11-30
CS9100055A2 (en) 1991-08-13
EP0437415A2 (de) 1991-07-17
EP0437415A3 (en) 1992-01-22
NO175747B (no) 1994-08-22
PL166157B1 (pl) 1995-04-28
MTP1076B (en) 1991-09-30
DK0437415T3 (da) 1995-09-18
GR3017027T3 (en) 1995-11-30
AU6928091A (en) 1991-07-18
CN1055739A (zh) 1991-10-30
HU216192B (en) 2001-03-28
PL288653A1 (en) 1991-12-16
NO910137L (no) 1991-07-15
IL96879A (en) 1995-06-29
FI94528C (fi) 1995-09-25
CN1037966C (zh) 1998-04-08
FI94528B (fi) 1995-06-15
ATE125809T1 (de) 1995-08-15
IL96879A0 (en) 1992-03-29
RU2021271C1 (ru) 1994-10-15
DZ1482A1 (fr) 2004-09-13
KR100191360B1 (ko) 1999-06-15
JPH04210982A (ja) 1992-08-03
CA2033937A1 (en) 1991-07-13
NZ236735A (en) 1992-10-28
ID964B (id) 1996-09-30
IE910103A1 (en) 1991-07-17
ZA91229B (en) 1991-08-28
KR910014376A (ko) 1991-08-31
RO107408B1 (ro) 1993-11-30
US5098911A (en) 1992-03-24
PT96447B (pt) 1998-09-30
FI910126A0 (fi) 1991-01-09
PL166500B1 (pl) 1995-05-31
TNSN91001A1 (en) 1992-10-25
PT96447A (pt) 1991-10-15
IE67512B1 (en) 1996-04-03
HUT56568A (en) 1991-09-30
HU910084D0 (en) 1991-08-28
ES2075399T3 (es) 1995-10-01
JP2694186B2 (ja) 1997-12-24
BG61489B2 (bg) 1997-09-30
EP0437415B1 (de) 1995-08-02
DE59106101D1 (de) 1995-09-07
PL167164B1 (pl) 1995-08-31
MA22040A1 (fr) 1991-10-01
NO910137D0 (no) 1991-01-11

Similar Documents

Publication Publication Date Title
BG60033B2 (bg) Метод за получаване на 4-(5,6,7,8-тетрахидроимидазо /1,5-а)пиридин-5-ил)бензонитрил-хидрохлорид в кристална полухидратна форма
IE781878L (en) Imidazole derivatives
GB1542980A (en) Process for the preparation of low molecular weight polyhydroxyl compounds and their use in the preparation of polyurethanes
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
JPS5395977A (en) 1,4-dihydropyrimidine compounds and process for their preparation
ES2125000T3 (es) Nuevas mezclas terapeuticas de hidratos de carbono utiles para ayudar en el sindrome premenstrual.
MY110092A (en) Butyric acid derivatives
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
ES8401074A1 (es) Sal de n-metil-d-glucamina.
ZA86286B (en) Imidazole derivatives,their preparation and therapeutic use
ES2006099A6 (es) Procedimiento para la obtencion de hidrocloruro de ciprofloxacina monohidrato.
JPS5612392A (en) Novel camptothecin derivative and its preparation
EP0363326A3 (en) Fungicidal amines
JPS5353698A (en) Pyrrolotriazolopyrimidine derivatives and their preparation
JPS5344597A (en) Condensed quinazolinol derivative
MY102063A (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
JPS54109971A (en) Novel furanoside derivative and its preparation
JPS5368800A (en) Cycloalkyl substd. pyrrolotriazolopyrimidine derivatives
JPS5363383A (en) 2-oxopiperidine derivatives and their preparation
JPS545997A (en) Novel hetrocyclic compounds and process for their preparation
JPS5345048A (en) Advanced treatment of waste water
JPS649992A (en) 1,8-crosslinked quinolincarboxylic acid derivative, ester thereof and salt thereof
SU1836846A3 (ru) Способ получения раствора бромида кальция
SU1533391A1 (ru) Состав для обработки призабойной зоны скважины
TH893A (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้